{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:06:25Z","timestamp":1792479985582,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Perinatology"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1053\/j.semperi.2005.05.011","type":"journal-article","created":{"date-parts":[[2005,8,14]],"date-time":"2005-08-14T11:06:53Z","timestamp":1124017613000},"page":"203-208","source":"Crossref","is-referenced-by-count":38,"title":["Second Trimester Serum Markers"],"prefix":"10.1053","volume":"29","author":[{"given":"Jacob A.","family":"Canick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"MacRae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semperi.2005.05.011_bib1","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/0002-9378(84)90530-1","article-title":"An association between low maternal serum alpha-fetoprotein and fetal chromosome abnormalities","volume":"148","author":"Merkatz","year":"1984","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/j.semperi.2005.05.011_bib2","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/pd.1970070904","article-title":"Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities","volume":"7","author":"Bogart","year":"1987","journal-title":"Prenat Diagn"},{"key":"10.1053\/j.semperi.2005.05.011_bib3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1471-0528.1988.tb06601.x","article-title":"Low second trimester maternal serum unconjugated estriol in pregnancies with Down\u2019s syndrome","volume":"95","author":"Canick","year":"1988","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1053\/j.semperi.2005.05.011_bib4","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1471-0528.1988.tb06602.x","article-title":"Maternal serum unconjugated oestriol as an antenatal screening test for Down\u2019s syndrome","volume":"95","author":"Wald","year":"1988","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1053\/j.semperi.2005.05.011_bib5","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/bmj.297.6653.883","article-title":"Maternal serum screening for Down\u2019s syndrome in early pregnancy","volume":"297","author":"Wald","year":"1988","journal-title":"Br Med J"},{"key":"10.1053\/j.semperi.2005.05.011_bib6","article-title":"ACOG Committee Opinion. Down syndrome screening","year":"1994","journal-title":"Committee on Obstetric Practice, Am Col Obstet Gynecol"},{"key":"10.1053\/j.semperi.2005.05.011_bib7","article-title":"ACOG Educational Bulletin. Maternal serum screening","year":"1996","journal-title":"Am Col Obstet Gynecol"},{"key":"10.1053\/j.semperi.2005.05.011_bib8","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0002-9378(97)70400-9","article-title":"Maternal serum screening for Down syndrome in the United States","volume":"176","author":"Palomaki","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/j.semperi.2005.05.011_bib9","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/pd.1970121005","article-title":"Second trimester maternal serum immunoreactive inhibin as a marker for fetal Down\u2019s syndrome","volume":"12","author":"Van Lith","year":"1992","journal-title":"Prenat Diagn"},{"key":"10.1053\/j.semperi.2005.05.011_bib10","first-page":"A9","article-title":"Maternal serum dimeric inhibin is elevated in Down syndrome pregnancy","volume":"55","author":"Canick","year":"1994","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.semperi.2005.05.011_bib11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/096914139600300202","article-title":"Second trimester levels of maternal serum inhibin-A, total inhibin, \u03b1 inhibin precursor and activin in Down\u2019s syndrome pregnancies","volume":"3","author":"Lambert-Messerlian","year":"1996","journal-title":"J Med Screen"},{"key":"10.1053\/j.semperi.2005.05.011_bib12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/(SICI)1097-0223(199602)16:2<143::AID-PD825>3.0.CO;2-F","article-title":"Prenatal screening for Down\u2019s syndrome using inhibin-A as a serum marker","volume":"16","author":"Wald","year":"1996","journal-title":"Prenat Diagn"},{"key":"10.1053\/j.semperi.2005.05.011_bib13","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJM199605093341904","article-title":"Dimeric inhibin-A as a marker for Down\u2019s syndrome in early pregnancy","volume":"334","author":"Aitken","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semperi.2005.05.011_bib14","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/(SICI)1097-0223(199612)16:12<1095::AID-PD997>3.0.CO;2-9","article-title":"Combining inhibin A with existing second-trimester markers in maternal serum screening for Down\u2019s syndrome","volume":"16","author":"Cuckle","year":"1996","journal-title":"Prenat Diagn"},{"key":"10.1053\/j.semperi.2005.05.011_bib15","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/(SICI)1097-0223(199612)16:12<1101::AID-PD5>3.0.CO;2-7","article-title":"Second trimester dimeric inhibin-A in Down\u2019s syndrome screening","volume":"16","author":"Spencer","year":"1996","journal-title":"Prenat Diagn"},{"key":"10.1053\/j.semperi.2005.05.011_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1365-2265.1996.544368.x","article-title":"Second trimester screening for Down\u2019s syndrome using serum dimeric inhibin-A","volume":"44","author":"Wallace","year":"1996","journal-title":"Clin Endocrinol"},{"key":"10.1053\/j.semperi.2005.05.011_bib17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1258\/096914103321824133","article-title":"First and second trimester antenatal screening for Down\u2019s syndrome","volume":"10","author":"Wald","year":"2003","journal-title":"J Med Screen"},{"key":"10.1053\/j.semperi.2005.05.011_bib18","unstructured":"Malone FD, Canick JA, Ball RH, et al: First and second trimester evaluation of risk for fetal aneuploidy (FASTER): Principal results of the NICHD multicenter Down syndrome screening study. N Engl J Med 2005 (in press)"},{"key":"10.1053\/j.semperi.2005.05.011_bib19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/jms.5.3.115","article-title":"Second trimester screening for Down\u2019s syndrome using maternal serum dimeric inhibin A","volume":"5","author":"Haddow","year":"1998","journal-title":"J Med Screen"},{"key":"10.1053\/j.semperi.2005.05.011_bib20","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0272-2712(03)00023-4","article-title":"Epidemiologic monitoring of prenatal screening for neural tube defects and Down syndrome","volume":"23","author":"Knight","year":"2003","journal-title":"Clin Lab Med"},{"key":"10.1053\/j.semperi.2005.05.011_bib21","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/clinchem\/45.12.2109","article-title":"Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay","volume":"45","author":"Cole","year":"1999","journal-title":"Clin Chem"},{"key":"10.1053\/j.semperi.2005.05.011_bib22","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/(SICI)1097-0223(199910)19:10<918::AID-PD680>3.0.CO;2-4","article-title":"Maternal urine hyperglycosylated hCG in pregnancies with Down syndrome","volume":"19","author":"Cuckle","year":"1999","journal-title":"Prenat Diagn"},{"key":"10.1053\/j.semperi.2005.05.011_bib23","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1373\/clinchem.2004.032839","article-title":"Second-trimester maternal serum invasive trophoblast antigen","volume":"50","author":"Pandian","year":"2004","journal-title":"Clin Chem"},{"key":"10.1053\/j.semperi.2005.05.011_bib24","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1373\/clinchem.2004.038059","article-title":"Maternal serum invasive trophoblast antigen (hyperglycosylated hCG) as a screening marker for Down syndrome during the second trimester","volume":"50","author":"Palomaki","year":"2004","journal-title":"Clin Chem"},{"key":"10.1053\/j.semperi.2005.05.011_bib25","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1373\/clinchem.2003.023986","article-title":"Invasive trophoblast antigen (hyperglycosylated human chorionic gonadotropin) in second-trimester maternal urine as a marker for Down syndrome","volume":"50","author":"Palomaki","year":"2004","journal-title":"Clin Chem"}],"container-title":["Seminars in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000505000455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000505000455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T00:46:11Z","timestamp":1586393171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146000505000455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0146000505000455"],"URL":"https:\/\/doi.org\/10.1053\/j.semperi.2005.05.011","relation":{},"ISSN":["0146-0005"],"issn-type":[{"value":"0146-0005","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}